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Aminoglycoside antibiotics are widely prescribed to treat a variety of serious bacterial
infections. They are extremely useful clinical tools, but have adverse side effects such
as oto- and nephrotoxicity. Once inside a cell they are thought to cause mitochondrial
dysfunction, subsequently leading to apoptotic cell death due to an increase in reactive
oxygen species (ROS) production. Here we present evidence of a direct effect of
gentamicin (the most commonly prescribed aminoglycoside) on the respiratory activities
of isolated rat liver and kidney mitochondria. We show that gentamicin stimulates state
4 and inhibits state 3u respiratory rates, thereby reducing the respiratory control ratio
(RCR) whilst simultaneously causing a collapse of the mitochondrial membrane potential
(MtMP). We propose that gentamicin behaves as an uncoupler of the electron transport
chain (ETC) – a hypothesis supported by our evidence that it reduces the production of
mitochondrial ROS (MtROS). We also show that gentamicin collapses the MtMP in the
sensory hair cells (HCs) of organotypic mouse cochlear cultures.
Keywords: aminoglycoside, gentamicin, mitochondria, bioenergetics, hair cell, ototoxicity
INTRODUCTION
Aminoglycosides (AGs) are broad-spectrum antibiotics widely prescribed to treat serious bacterial
infections such as those leading to septicaemia and meningitis. Although extremely effective
clinical agents, they carry the unfortunate risk of adverse side effects such as oto- and nephro-
toxicity – damage to hearing and kidney function, respectively, (Mingeot-Leclercq and Tulkens,
1999; Forge and Schacht, 2000; Selimoglu, 2007; Wargo and Edwards, 2014). Nephrotoxicity
occurs in approximately 60% of patients treated with AGs (Oliveira et al., 2009). Fortunately
this damage is reversible, due to the regenerative abilities of the kidney. However, permanent
hearing loss is found in around 20–30% of patients treated with these antibiotics (Rizzi and Hirose,
2007; Schacht et al., 2012), presenting a much more significant clinical concern. The damage to
these organs is assumed to be attributable to the selective retention of AGs within these tissue
types, with endocytic and non-selective cation channel-mediated routes in kidneys (Nagai and
Takano, 2014) and the mechano-electrical transducer (MET) channels of cochlear sensory hair
cells (HCs) (Marcotti et al., 2005; Alharazneh et al., 2011) proposed as the main entry pathways.
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Once inside a cell AGs are thought to interact with
mitochondria, resulting in their dysfunction and the consequent
induction of apoptotic cell death cascades. This assumption is
based upon several pieces of evidence. Firstly, the remarkable
similarity of the structure of mitochondria to that of bacteria
(the intended target of AGs) and their proposed bacterial
origin indicate that they may represent a secondary target
of the antibiotics (Margulis, 1970; Gray et al., 2001; Gray,
2012). Secondly, fluorescence imaging studies showing the
co-localization of a fluorescent AG conjugate (gentamicin-
Texas Red) with mitochondrial stains such as Mitotracker
(Ding et al., 1995; Steyger et al., 2003), suggest that they are
trafficked to these organelles once inside the cell. Moreover,
point mutations in mitochondrial DNA lead to enhanced
susceptibility to AG-induced toxicity (Prezant et al., 1993), again
signifying mitochondrial involvement. Lastly, prior to cell death,
cells treated with AGs show an increase in the intracellular
concentration of reactive oxygen species (ROS) (Clerici et al.,
1996; Hirose et al., 1997; Sha and Schacht, 1999) – reactive
molecules produced primarily by mitochondria. Taken together
these data suggest that mitochondria are a secondary target
of the AGs, and that perhaps the resultant mitochondrial
dysfunction is the underlying cause of cell death following AG
entry and accumulation.
The electron transport chain (ETC) is the driver of oxidative
phosphorylation and is the target of a large number of
drugs, including several anti-cancer compounds (Rohlena et al.,
2011; Kluckova et al., 2013; Olszewska and Szewczyk, 2013).
Cisplatin, another nephro- and ototoxicity-inducing compound
used to treat several forms of cancer (Skinner et al., 1998;
Knight et al., 2005), has been reported to cause mitochondrial
dysfunction as a crucial pathogenic event in its induction
of nephrotoxicity (Simmons and Humes, 1979). Furthermore,
previous studies investigating the effect of gentamicin on renal
tissue mitochondria have reported an effect on their state 3 and
state 4 respiratory activities, potentially underlying the associated
nephrotoxicity (Bendirdjian et al., 1975, 1978; Simmons et al.,
1980). However, documentation of the mechanisms underlying
the increase in state 4 and decrease in state 3 respiratory
activities is lacking. Moreover, the effect of the AGs on cochlear
sensory hair cell mitochondria is not fully understood. Studies
have reported that AGs trigger the opening of the permeability
transition pore, thereby dissipating the mitochondrial membrane
potential (MtMP) (Dehne et al., 2002). More recent studies,
however, suggest that disruption of the endoplasmic reticulum
(ER), or more specifically calcium signaling from the ER to
mitochondria, is the earliest pathological event underlying AG-
induced ototoxicity (Esterberg et al., 2013, 2014, 2016; Hailey
et al., 2017; O’Sullivan et al., 2017).
Here, we present evidence of the direct effect of the AGs on
the respiratory function and activity of isolated rat liver and
kidney mitochondria. We conducted oxygen consumption assays
to investigate the function of the ETC, alongside performing
fluorescence-based assessments of the MtMP and mitochondrial
ROS (MtROS) production using safranin and Amplex Red dyes,
respectively. MtMPs in the sensory HCs of mouse cochlear
cultures were also investigated using Rhodamine-123.
Our data suggest that gentamicin, the most commonly
prescribed aminoglycoside (Eltahawy and Bahnassy, 1996;
Gonzalez, and Spencer, 1998; Xie et al., 2011), stimulates
state 4 (non-phosphorylating respiration) and inhibits state 3u
(uncoupled) respiratory rates, thereby reducing the respiratory
control ratio (RCR) of isolated mitochondria. Our evidence also
suggests that gentamicin does not result in MtROS production in
isolated mitochondria, but rather reduces its generation. Lastly,
we highlight that the documented effects observed in whole
cell systems also occur in our isolated mitochondrial assays,
suggesting that mitochondria can initiate the effects induced by
AGs independent of any input from the ER.
MATERIALS AND METHODS
Isolation of Rat Liver and Kidney
Mitochondria
Sprague-Dawley rats of either sex were killed by two methods
depending on their weight, according to Home Office
(United Kingdom) guidelines. If weighing less than 150 g,
cervical dislocation was used whereas if the weight was
over 150 g, the rat was killed by exposure to slowly rising
concentrations of CO2 over a period of 10 min. No difference
in mitochondrial function was detected between these two
methods, both in terms of respiratory rates and also the response
to gentamicin exposure. 25 rats (16 males and 9 females) were
used for the experiments presented herein. All rats were within
the age range of 1–3 months. Age and sex differences were not
investigated. However, comparisons were made regarding the
effects of gentamicin on tissue from each animal, so any unequal
distribution of animal age/sex would not be a confounding,
extraneous variable to the effects that were detected.
The liver or kidney was dissected and transferred to ice
cold, 18.2 M resistivity water for approximately 1 min before
being placed in buffer solution containing 1 mM EGTA, 30 mM
MOPS, 250 mM sucrose, 3.5 mM L-cysteine and 0.1% BSA, pH
adjusted to 7.6 using NaOH. The tissue was homogenized with 10
passes in a loose-fitting, followed by 10 passes in a tight-fitting,
homogenizer. After filtering through muslin the homogenate
underwent differential centrifugation at 4◦C – initially at 1000 g
(after which the supernatant was kept and pellet discarded) and
then twice at 10,000 g, each for 10 min. After each centrifugation
the supernatant was discarded, and the mitochondrial pellet
was re-suspended in a small aliquot of buffer solution. Isolated
mitochondria were kept on ice before being transferred to the
oxygen electrode chambers for the initiation of experimentation.
Mitochondrial protein content was estimated using the
Bradford method (He, 2011), with Bio-Rad protein assay dye.
Measurement of Mitochondrial
Respiration
Oxygen consumption rates of isolated mitochondria were
measured using an Oroboros Oxygraph-2K oxygen electrode.
Assays were performed in rat media containing 200 mM sucrose,
25 mM KCl, 11 mM MgCl2, 5 mM KH2PO4, 5 mM MOPS,
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pH adjusted to 7.4 using NaOH. Approximately 600 µg of
crudely isolated mitochondrial sample was added to the chamber
containing 2 ml assay media and allowed to equilibrate for
10 min. The reaction was then initiated with both 5 mM
pyruvate and 2 mM malate for complex I-, or 10 mM
succinate in the presence of 0.5 µM rotenone for complex II-
dependent respiration. Uncoupled respiration was achieved with
the addition of 0.5–2 µM CCCP, and complex IV respiration was
investigated by addition of 8 mM ascorbate and 4 mM TMPD. All
experiments were performed at 32◦C.
Measurement of Respiratory Chain
Complexes
All assays were performed via UV-Vis spectroscopy in a 96-
well plate format, using a Thermo Scientific Multiskan Go with
the Skanit 4.1 software package. Each assay was performed with
approximately 100 µg mitochondrial isolate in the same rat
media described in measurement of mitochondrial respiration.
Prior to the assay, mitochondrial samples were subjected to 2
freeze-thaw cycles to permeabilize the membranes.
Complex I
Complex I activity was measured by a protocol adapted from
that described in Long et al. (2009). Briefly, 600 µM NADH was
added to wells containing ∼ 50 µg mitochondria, followed by
50 µM ubiquinone-2, 2 µM antimycin A and 1 mM KCN in
the rat media described above. The rate of NADH oxidation was
measured at 350 nm for 10 min.
Complex II
Complex II activity was determined by following the reduction
of DCPIP at 600 nm over 10 min. The well contained ∼ 50 µg
mitochondria in rat media containing 50 µM ubiquinone-2,
74 µM of DCPIP and the reaction was initiated with 100 µM
succinate. The protocol was adapted from Medja et al. (2009).
Complex III
The activity of complex III was measured by following the rate of
reduction of cytochrome C at 550 nm over 5 min. The reaction
was initiated by adding 50 µM ubiquinol 2 to wells containing
mitochondria in rat media, 64 µM cytochrome C and 1 mM
KCN. The protocol was adapted from Medja et al. (2009).
Measurement of Mitochondrial
Membrane Potential and ROS Production
The MtMP was investigated with the use of safranin, a biological
stain with an excitation wavelength of 495 nm and an emission
wavelength of 587 nm. An initial calibration was performed
prior to each experiment by titrating safranin between final
concentrations of 0.1 and 2.0 µM in rat media (Krumschnabel
et al., 2014). Following calibration, ∼600 µg mitochondrial
protein was added and a basal signal (0%) was recorded.
A membrane potential was generated upon the addition of
10 mM succinate in the presence of 2.5 µM rotenone, and the
sample was subsequently titrated against gentamicin.
Mitochondrial ROS production was measured using Amplex
Red, a dye with an excitation wavelength of 563 nm and
an emission wavelength of 587 nm. Initial calibrations were
performed by first adding 10 µM Amplex Red, 1 U/ml
horseradish peroxidase and 5 U/ml superoxide dismutase to rat
media for a baseline, with 0.1 µM hydrogen peroxide added to
calibrate the signal. Approximately 600µg mitochondrial protein
was added and incubated for 10 min in the presence or absence of
5 mM gentamicin, and respiration was initiated with the addition
of 10 mM succinate.
Measurement of MtMP in Mouse
Cochlear Culture Sensory Hair Cells
Rhodamine-123 (1 mg/ml; Vector Laboratories, United States)
was diluted 1:200 in an extracellular solution containing:
135 mM NaCl, 5.8 mM KCl, 1.3 mM CaCl2, 0.9 mM MgCl2,
0.7 mM NaH2PO4, 5.6 mM D-glucose, 10 mM HEPES-
NaOH. MEM (Minimal Essential Medium) amino acids and
vitamins, and sodium pyruvate (2 mM) were added from
stock concentrates (Fisher Scientific). Cochlear cultures were
prepared from postnatal day 2 CD-1 wild type mice of either
sex, maintained for 24 h in vitro, rinsed 3 times in phosphate
buffered saline (PBS) and then incubated in 1 ml of the
Rhodamine-123 solution for 15 min at 37◦C. Cultures were
subsequently rinsed 3 times in PBS and placed in the microscope
chamber containing extracellular solution. The sensory HCs
were observed with an upright microscope (Olympus) with a
60X water-immersion objective (NA = 0.9). Fluorescence images
were obtained using a Visitech VT-Infinity3 confocal system
and VoxCell Scan software. Gentamicin (50 mg/ml; Sigma)
was added to the recording chamber to a final concentration
of 1–20 mM. Fluorescence images were obtained at regular
intervals (2–10 min).
The materials used in all the experiments detailed were
purchased from Sigma, United Kingdom, unless otherwise stated.
Statistics
For statistical analyses, p < 0.05 was the criterion used for
statistical significance. Multiple comparisons were made using
1-way ANOVA with Dunnett or Tukey post hoc tests. Means
are quoted and shown in Figures ± SEM. ‘N’ denotes the
number of rats used and ‘n’ the number of mitochondrial samples
tested. Level of statistical significance is shown in Figures as
follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Dose-response
curves were fit using non-linear regression, with nH denoting the
Hill Coefficient. All statistical analysis was performed with the
Graphpad Prism v7.0 software package.
RESULTS
Gentamicin Stimulates State 4 and
Inhibits State 3u Respiratory Rates in
Isolated Rat Liver Mitochondria
The assessment of overall mitochondrial activity was performed
by measuring oxygen uptake using an Oroboros Oxygraph,
taking advantage of the dual chamber set-up for running
control experiments simultaneously. Mitochondrial samples
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FIGURE 1 | A typical respiratory flux trace for complex II (CII) respiration, alongside quantification of the complex I (CI) and CII responses. (A) Approximately 600 µg
of mitochondrial protein was pre-incubated in rat medium ±5 mM gentamicin for 10 min. Upon addition of 10 mM succinate (+), a greater oxygen consumption rate
can be seen in the sample containing gentamicin (red). Subsequent addition of 1 µM CCCP (++), causes O2 flux to rise significantly in the control (green), whereas
this effect is reduced in the gentamicin sample. (B) Quantification of the CI response, with 5 mM pyruvate, 10 mM glutamate and 2 mM malate addition to stimulate
internal NADH generation (N = 2, n = 4). (C) Quantification of the CII response, with 10 mM succinate and 1 µM CCCP used to generate the response (N = 5,
n = 14–26).
were equilibrated in reaction medium with or without 5 mM
gentamicin for 10 min prior to the addition of 10 mM succinate,
in the presence of 2.5 µM rotenone to ensure that nicotinamide
adenine dinucleotide (NADH) generated within the tricarboxylic
acid (TCA) cycle did not become a factor contributing to
oxygen flux. Upon addition of the substrate, oxygen consumption
increased to 240.9 (±22.1) pmol O2 s−1 ml−1 (N = 5,
n = 26) within the control samples and 419.6 (±48.5) pmol
O2 s−1 ml−1 (N = 5, n = 14) in the gentamicin-treated conditions,
demonstrating a just significant (p = 0.05) stimulation of
complex II-based state 4 respiration (Figures 1A,C). Subsequent
addition of 1 µM carbonyl cyanide m-chlorophenyl hydrazone
(CCCP), to uncouple oxygen consumption rates from oxidative
phosphorylation, increased the rate of respiration to 807.2
(±57.4) pmol O2 s−1 ml−1 (N = 5, n = 26) within
the control samples. However, the gentamicin-induced rate
remained relatively stable at 406.6 (±40.9) pmol O2 s−1 ml−1
(N = 5, n = 14) and was not significantly changed relative to the
coupled state (Figures 1A,C).
To ensure the effect was not limited to succinate-dependent
respiration, the same set of experiments was run using 5 mM
pyruvate, 10 mM glutamate and 2 mM malate to stimulate
internal NADH, thereby investigating the complex I respiratory
pathway. As with the previous set of experiments, the gentamicin-
treated mitochondria had a significantly (p = 0.0059) higher
rate of state 4 respiration in comparison to the control, with
the rate increasing from 149.8 (±15.4) pmol O2 s−1 ml−1
(N = 2, n = 4) in the controls to 502.5 (±72.7) pmol
O2 s−1 ml−1 (N = 2, n = 4) in those treated with
gentamicin. Furthermore, respiratory activity in the presence
of gentamicin did not increase when treated with CCCP,
measuring 402.3 (±85.0) pmol O2 s−1 ml−1 (N = 2, n = 4),
and was not significantly different relative to the coupled
rate (Figure 1B).
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FIGURE 2 | Gentamicin reduces the respiratory control ratio (RCR) of isolated mitochondria in a dose- and time-dependent manner. (A) Increase in complex II
succinate-induced O2 flux (state 4) with increasing gentamicin concentrations, and a simultaneous reduction in the CCCP-induced O2 flux (state 3u). Experiments
were done in the presence of 2.5 µM rotenone, to inhibit complex I respiration. Lines are fit to a linear regression model, displaying 95% confidence intervals (N = 13,
n = 3–26). (B) Transformed data, with RCRs derived by dividing the CCCP-induced O2 consumption rates (state 3u) by the succinate-induced O2 consumption rates
(state 4) (EC50 3.6 mM, nH 2.4). (C) Decrease in the RCR with increasing gentamicin incubation times, for three different gentamicin concentrations (2.5, 5, and
7.5 mM) (N = 1, n = 1). (D) Dose-response curve for state 3u respiration with gentamicin at t = 10, with an IC50 of 9.5 mM (95% CI 8.4–11.0 mM, nH 1.54)
(N = 1, n = 3).
Furthermore, there was a significant difference in the
uncoupled respiratory rates between the control and gentamicin-
treated conditions, both for complex I (p = 0.0375) and
complex II-mediated (p < 0.0001) respiration (Figures 1B,C).
This implies that gentamicin reduces state 3u respiratory rates,
as has previously been reported elsewhere in the literature
(Simmons et al., 1980).
Gentamicin Reduces the Respiratory
Control Ratio of Isolated Rat Liver
Mitochondria
Given that gentamicin stimulates state 4 and causes a concurrent
reduction of state 3u respiratory rate (Figure 1), we investigated
its effect upon the RCR. Initial dose-response experiments were
performed at a fixed 10 min incubation time point, with the
data displaying a clear concentration-dependent increase in
state 4 respiratory rates (Figure 2A; circles). While the data
for uncoupled respiration initially appears erratic (Figure 2A;
squares), this is likely due to the non-homogenous nature of
the mitochondrial sample making uniform protein addition
problematic, and errors becoming more apparent in the faster
state 3u rates (N = 13, n = 26). However, once the data
is transformed into RCR values by dividing the uncoupled
respiratory rates (state 3u) by the succinate-induced O2
consumption rates (state 4), a typical dose-response effect can be
observed (Figure 2B).
The extent to which incubation time was a factor was also
investigated (Figure 2C). All three gentamicin concentrations
tested (2.5, 5, and 7.5 mM) demonstrated a linear reduction in
RCR as the length of incubation time increased (N = 1, n = 1).
Dose-response curves (Figure 2D) were generated at t = 10 min
for state 3u respiration, and an IC50 of 9.5 (±2.5) mM (N = 1,
n = 3) was determined.
Gentamicin Inhibits Complex II and
Complex III of the ETC
In order to ascertain if the effects of gentamicin summarized
in the above Figures were due to inhibition of the ETC, the
overall activities of the complexes were tested in isolation.
As with the previous experiments, incubation with 5 mM
gentamicin for 10 min prior to the addition of 10 mM
succinate and 1 µM CCCP resulted in a reduced state 3u
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FIGURE 3 | Dose-response curves of isolated mitochondrial protein as a function of gentamicin concentration. (A) Inhibition of complex II in isolation, determined by
the decrease in rate of DCPIP reduction at 600 nm, giving an IC50 of 17 mM (95% CI 14.7–21.6 mM, nH 3.8) for gentamicin. (B) Inhibition of complex III, determined
by the decrease in cytochrome C reduction at 550 nm rate using ubiquinol-2 as a substrate. The IC50 of gentamicin was determined to be 1.94 mM (95% CI
0.7–1.7 mM, nH 1.2). For both panels N = 3, n = 3.
FIGURE 4 | Gentamicin depolarizes the mitochondrial membrane potential (MtMP) in a concentration-dependent manner. (A) Succinate is added to the chamber to
initiate respiration (+). This generates a proton gradient and consequent polarization of the mitochondrial membrane, shown by the quenching of the signal. When
gentamicin is added to the chamber in 2.5 mM increments (↓) up to a concentration of 15 mM, there is a rapid, direct increase in safranin signal, suggesting that
gentamicin is dissipating the proton gradient and depolarizing the MtMP. (B) Quantification of the results, with data normalized between addition of succinate and
safranin (100 and 0%, respectively). A significant shift in safranin signal relative to succinate only is evident at gentamicin concentrations ≥1 mM (N = 3, n = 3).
respiratory rate when compared to the control, but subsequent
addition of 8 mM ascorbate and 4 mM N,N,N′,N′-Tetramethyl-
p-phenylenediamine dihydrochloride (TMPD) together (to act
as electron donors to cytochrome C) restored the oxygen
consumption rates to 779 (±99) pmol O2 s−1 ml−1 and
814 (±43) pmol O2 s−1 ml−1 (N = 2, n = 3) for the
control and gentamicin-treated samples, respectively. These rates
were not significantly different from each other suggesting
that the antibiotic had no direct effect upon complex IV
(data not shown).
In order to investigate the effects of gentamicin on complexes
I, II and III, a spectrophotometric technique was used to
measure the activity of individual complexes. When the activity
of complex I was measured in the presence of 2 µM Antimycin
A and 50 µM ubiquinone-2 as the electron acceptor, to ensure
complete isolation of complex I, a discernible reduction in
NADH oxidation rate was not detectable up to a gentamicin
concentration of 40 mM (data not shown).
Complex II activity was determined by following the reduction
of DCPIP at 600 nm in the presence of 2 µM Antimycin A and
50 µM ubiquinone-2. Given the previously demonstrated time-
dependent nature of inhibition, the mitochondria were incubated
with gentamicin for 10 min prior to the addition of succinate.
Figure 3A shows that the reduction rate of DCPIP reduces in
response to gentamicin in a dose-dependent manner with an
IC50 of 17 mM, indicating an inhibition of electron transfer
from complex II.
The respiratory rate of complex III was measured by following
the rate of cytochrome C reduction using 50 µM ubiquinol 2 in
the presence of 1 mM cyanide (KCN) to prevent electron transfer
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FIGURE 5 | The effect of gentamicin on mitochondrial H2O2 (ROS) production. (A) H2O2 levels detected over a period of 10 min, with the rates of production and
overall concentrations plotted. Solid lines display Amplex signal (H2O2 concentration), dotted lines display rates of H2O2 production. Green is control sample, red is
pre-treated with gentamicin. Following succinate addition (10 mM) (+), the formation of H2O2 is reduced in samples that were pre-incubated for 10 min with 5 mM
gentamicin. (B) Shows quantification of the increase in cumulative H2O2 over a 10 min period, with final concentrations plotted (N = 3, n = 3). Gentamicin reduces
endogenous ROS production.
to complex IV. As with the complex II assays, Figure 3B shows
that gentamicin provides a clear dose-dependent reduction in the
rate of electron transfer, with an IC50 value of 1.94 mM. Given
that the previous assays with intact mitochondria demonstrated a
reduction in state 3u respiration rates when pyruvate, glutamate
and malate (complex I) and succinate (complex II) were
used as substrates, it is highly likely that this is due to the
inhibition of complex III.
Gentamicin Depolarizes the
Mitochondrial Membrane Potential
Given the apparent effect of gentamicin on the mitochondrial
RCR, we investigated its effect on the MtMP using safranin as an
indicator of membrane potential (Åkerman and Wikström, 1976;
Krumschnabel et al., 2014). Initial addition of safranin (2 µM)
to the mitochondrial preparation generates the fluorescent
signal. Subsequent addition of succinate (Figure 4A+) in the
presence of 2.5 µM rotenone initiates respiration and a proton
gradient is formed, with the safranin signal decreasing due to its
accumulation within the mitochondrial matrix. Upon addition
of 2.5 mM gentamicin (Figure 4A↓) the MtMP gradually
depolarizes, with successive 2.5 mM additions (Figure 4A↓)
causing further depolarization.
Figure 4B shows quantification of the results. A significant
shift in safranin signal relative to succinate only is evident
at gentamicin concentrations ≥1 mM (p = 0.009) (N = 3,
n = 3). As shown in Figure 4A, complete dissipation of the
gradient is observed with successive additions of gentamicin
up to a final concentration of 15 mM. However, if lower
concentrations of gentamicin (≥1 mM) are added and
incubated in the chamber then a progressive depolarization
of the MtMP is observed over time (data not shown),
suggesting that gentamicin must first cross the outer
mitochondrial membrane (OMM) in order to exert its
effect on the respiratory proteins embedded within the inner
mitochondrial membrane (IMM).
Gentamicin Reduces Mitochondrial ROS
Production With Succinate as the
Substrate
Mitochondrial ROS production can be measured using
Amplex Red, a dye that fluoresces dependent on hydrogen
peroxide (H2O2) levels. Endogenous H2O2 production by
isolated rat liver mitochondria was measured following the
addition of succinate (Figure 5A+). Pre-incubation with
5 mM gentamicin for 10 min caused a reduction in the
amount of H2O2 produced over a subsequent 10-min time
period (Figure 5A).
Quantification of the increase in H2O2 concentrations over
time is shown in Figure 5B, with final H2O2 concentrations
generated after 10 min plotted. When compared to the control,
there was a significant reduction in the amount of ROS generated
when mitochondria were incubated with 1 (p = 0.0167) and 5
(p = 0.0080) mM gentamicin (N = 3, n = 3).
Gentamicin Causes State 4 Stimulation
and State 3u Inhibition, RCR Reduction,
MtMP Depolarization and a Reduction in
MtROS Production in Isolated Rat
Kidney Mitochondria
Isolated rat liver mitochondria were used for all of the
experiments detailed above due to the ease of isolation and the
high yield of mitochondria per dissection. However, as this is not
an organ that is damaged by AGs, all experiments were repeated
with kidney mitochondria to ensure the same effect was seen, as
the kidney is susceptible to AG-induced (nephro-) toxicity and
thus represents a more clinically relevant mitochondrial subtype.
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FIGURE 6 | The effect of gentamicin on respiratory parameters in isolated rat kidney mitochondria. (A) Succinate addition (+) in the gentamicin condition causes a
much larger O2 flux response than in the control. Subsequent addition of 1 µM CCCP (++), an uncoupler of the ETC, causes O2 flux to rise significantly in the control
(green), whereas a greatly reduced rise is seen when pre-incubated with gentamicin (red). (B) Quantification of the results shows that gentamicin causes a
concentration-dependent decrease in the RCR of isolated kidney mitochondria. (C) Succinate is added to the chamber to initiate respiration (+), generating a proton
gradient and consequent hyperpolarization of the mitochondrial membrane. When gentamicin is added to the chamber in 1 mM increments (↓) there is a sudden
increase in safranin signal, suggesting that gentamicin is dissipating the proton gradient and depolarizing the MtMP. (D) Shows H2O2 levels detected over a period of
10 min, with the rates of production and overall concentrations plotted. Solid lines display concentrations, dashed lines display rates. Green is control, red is
gentamicin. Following 10 mM succinate addition (+), the endogenous formation of ROS is inhibited by gentamicin (N = 1, n = 1).
Moreover, differences have been detected in the functioning
of the ETC in mitochondria isolated from different organs
(Lotz et al., 2014). It was therefore important to establish that
similar effects of gentamicin could also be observed in isolated
kidney mitochondria.
As shown in Figure 6A, the same stimulation of state 4
and reduction of state 3u respiratory rates were observed,
with concurrent reduction in the RCR of kidney mitochondria
(Figure 6B). To note, the RCR of kidney mitochondria
is much lower than that of liver mitochondria, with an
average RCR of 5.28 (±0.83) (N = 1, n = 4) relative to
that of the liver, which was 9.04 (±0.56) (N = 1, n = 8).
This observation is in agreement with a previous report
(Lash and Jones, 1993).
Depolarization of the MtMP occurred with serial gentamicin
additions (Figure 6C), with a complete collapse of the MtMP
at gentamicin concentrations ≥5 mM (N = 1, n = 1). This is
a slight reduction from the 15 mM concentration required to
dissipate the MtMP in the liver mitochondria, and we are unable
to explain the reason for this at this time. However, given that
gentamicin is nephrotoxic, there is potential for mitochondrial
morphological differences between kidney and liver samples that
have contributed to the increased potency of the compound.
Lastly, gentamicin is shown to reduce ROS production in
kidney mitochondria also (Figure 6D), with endogenous ROS
levels following succinate addition (Figure 6D+) being greatly
reduced in the gentamicin-treated condition relative to the
control (N = 1, n = 1).
Gentamicin Causes MtMP Depolarization
in Sensory Hair Cell Mitochondria
To assess whether the effects observed in isolated mitochondria
also occur in intact cell systems, and in particular in the
cochlea since it is susceptible to AG-induced ototoxicity, we
investigated the effect of gentamicin on the MtMPs in the
sensory HCs of mouse cochlear cultures. Previous studies have
shown a location-dependent effect of gentamicin on cochlear
culture HCs, with basal outer HCs losing their mitochondrial
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FIGURE 7 | Gentamicin causes a progressive loss of MtMP in mouse cochlear culture HCs after ≥16 min incubation time. (A–J) Confocal images show
Rhodamine-123 fluorescence in the three rows of outer HCs (OHCs) at differing time points following exposure to 5 mM gentamicin. Loss of fluorescence begins at
16 min post-exposure, with complete loss evident in one OHC (∗). The decrease in fluorescence indicates a collapse of the MtMP. By 26 min post-exposure the
majority of OHCs in the region of interest had reduced Rhodamine-123 fluorescence indicating a widespread loss of MtMP. The experiment was performed at room
temperature (20–22◦C). Scale bar is 25 µm.
metabolic activity more rapidly than those located in the apical
coil (Jensen-Smith et al., 2012).
Cells were pre-loaded with Rhodamine-123, a fluorescent
dye that stains mitochondria based on an active MtMP. If the
MtMP is dissipated, the fluorescence signal diminishes (Rahn
et al., 1991). Cells were bathed in extracellular solution and
gentamicin was added to a final concentration of 1, 5, 10 or
20 mM (n = 6 cochlear cultures). Figure 7 shows the HC
fluorescence over a period of 26 min in 5 mM gentamicin.
Between 0 and 14 min there was no change in the fluorescence
detected (Figures 7A–D). By 16 min incubation time, however,
the MtMPs in some HCs had dissipated (Figure 7E∗). By 26 min,
almost all of the HCs in the cochlear region under investigation
showed a loss of their MtMPs (Figure 7J). MtMP loss was
slower in 1 mM and faster in 10 and 20 mM gentamicin
(not shown). This directly correlates with that described above
in the isolated mitochondrial assay systems, adding further
confirmation that loss of the MtMP may be the process
underlying AG-induced ototoxicity.
DISCUSSION
The AGs have long been assumed to target mitochondria once
inside the cells of the tissue types that are susceptible to AG-
induced toxicity, including renal cells and the sensory HCs of
the cochlea. This has largely been based upon indirect lines of
evidence showing co-localization of fluorescent mitochondrial
dyes with fluorescently conjugated AGs (Ding et al., 1995;
Steyger et al., 2003), increased susceptibility to AG damage due
to mitochondrial DNA mutations (Prezant et al., 1993), and
inferences made on the basis of ROS production (Clerici et al.,
1996; Hirose et al., 1997; Sha and Schacht, 1999). Other lines
of evidence have also shown a direct effect of the AGs on the
respiratory activities of mitochondria and on the permeability of
their membranes. Here, we present an investigation of each of
these effects, developing a mechanistic hypothesis of how AGs
induce mitochondrial dysfunction.
Our initial investigation of isolated mitochondria indicated
that gentamicin causes an increase in state 4 respiration rates
independent of the initiating substrate, while also causing a
consistent reduction in the uncoupled rates, confirming studies
that have been undertaken by others previously (Weinberg
and Humes, 1980). Investigation of the isolated ETC proteins
indicates that inhibition of the cytochrome bc1 complex is
the primary cause for reduction in state 3u, which correlates
well with the reduction in uncoupled respiration rates when
either succinate or pyruvate, glutamate and malate were used
as substrates during the multi-complex assays, as complex III
is the convergence point for both complex I and complex
II pathways. While in vivo work has previously shown that
mitochondria isolated from gentamicin-treated rats have reduced
oxidative phosphorylation turnover (Sahu et al., 2014; Abuelezz
et al., 2016; Felix et al., 2017), these do not confirm that the
aminoglycoside affects the complexes directly. Gentamicin is
known to inhibit mitochondrial protein synthesis via interaction
with mitochondrial ribosomes (Hobbie et al., 2008), and as
such reduced respiratory capacity could be precipitated by
misfolded or reduced levels of ETC proteins. This would
explain the discrepancies between our work demonstrating a
lack of inhibition at complex I at these concentrations, and
others who have shown a reduction in activity of complex
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I in mitochondria isolated from gentamicin treated rats
(Abuelezz et al., 2016).
It should also be noted the IC50 was higher in the fully intact
mitochondrial samples than the permeabilized samples used in
the isolated enzyme assays, which would suggest the OMM is a
significant barrier to gentamicin entry. This is likely to be the
cause of the time-dependence seen in Figure 2C, as the internal
matrix concentration of the compound can equilibrate over time
with the external solution.
While the concentrations used within this study appear higher
than would typically be pharmacologically relevant, it has been
demonstrated previously that there is a significant uptake of
gentamicin into renal cortical tissue relative to the blood plasma
(up to a concentration of approximately 5 mM) (Simmons et al.,
1980). Given that we have demonstrated that the effects are
consistent in both liver and kidney mitochondria, it is likely
that the primary cause for differences seen in organ pathologies
is linked to gentamicin uptake into cells rather than organelle-
specific differences in mitochondrial function. AGs can readily
enter the sensory HCs of the inner ear specifically, through their
MET channels, and have been shown to accumulate at a very
high rate. Dihydrostreptomycin, a semisynthetic AG, when at
an extracellular concentration of 1 µM, has been estimated to
reach an intracellular concentration of 1µM within 80 s in OHCs
(Marcotti et al., 2005), corresponding to 1 mM in 22 h and
highlighting the rapid entry and accumulation rates of the AGs
into sensory HCs.
When taken in isolation, it is expected that inhibition of
complex III would lead to an increase in ROS production, as has
previously been shown with Antimycin A (Chen et al., 2003).
However, our results have shown that there is in fact a decrease
in ROS production in isolated mitochondria, indicating that
the increase in ROS levels seen in other studies (Clerici et al.,
1996; Hirose et al., 1997; Sha and Schacht, 1999) is not likely
mitochondrial in origin, and more likely to be generated by the
gentamicin-iron complexes that have been proposed by others
(Lesniak et al., 2005). Differences between our protocol and that
used by Walker (Walker and Shah, 1988) may also account for the
discrepancies between our results and the aforementioned study,
as the lack of mitochondrial turnover while the gentamicin is
incubating within this study may contribute to the lack of excess
peroxide generation. If the mitochondria are already uncoupled
prior to respiratory activation then there will not be a high
membrane potential, which will reduce RET through complex I,
one of the major sources of mtROS production. Other studies
(Walker and Shah, 1988; Yang et al., 1995) have also used
mitochondria from gentamicin treated rats, where the damage to
ETC proteins discussed earlier may cause an increase in the levels
of ROS generated.
While it would be tempting to speculate that the inhibition of
complex III is the primary cause for dissipation of the MtMP, due
to the decrease in proton pumping across the membrane, we do
not believe this to be the case. The reduction of the MtMP due to
increasing gentamicin concentration (Figure 4) runs concurrent
with the increase in state 4 rates (Figure 2A), suggesting there
has been a reduction in the proton-motive force thereby allowing
the complexes to turn over at a faster rate. It is also a reasonable
conclusion that the state 4 rate increase is not the result of
activation of any individual ETC complex, as when each complex
was tested in isolation, there was no increase in activity seen prior
to inhibition in the dose-response curves (Figure 3). However,
the reduction in the state 3u rates is also concurrent with the
increase in state 4 rates (Figure 2). This would suggest that either
there are two separate modes of action for gentamicin, one which
is due to inhibition of the individual complexes and one where it
dissipates the MtMP, or that the cause of reduction of the MtMP
also inhibits the action of the complexes. For the latter to be true,
it would suggest that gentamicin directly reduces the integrity
of the mitochondrial membrane, first allowing protons to leak
across, leading to a reduction in MtMP, followed by reduction of
the integrity of the complexes within the membrane.
The mouse cochlear cultures were used in order to confirm
our hypothesis that reduction in the MtMP preceded HC death
when exposed to gentamicin, and that dissipation of the gradient
is not limited to isolated mitochondrial samples. As can be seen
in Figure 7 there is progressive dissipation of the MtMP after
15 min of gentamicin exposure, which is substantially faster than
the 6 h in 1 mM (Dehne et al., 2002) and 10 h in 3 mM (Servais
et al., 2005) time periods that have been described by others Given
that the time frame for HC MtMP dissipation is similar to that of
isolated mitochondria, it would also appear to confirm that there
is rapid uptake of the compound into the cells. As the complete
dissipation of the MtMP would prevent ATP generation, HC
death would follow once cellular ATP stores have been depleted.
We propose that due to the time- and concentration-
dependent nature of both inhibition and uncoupling of the
proton-motive force the AGs must first permeate the OMM
before exerting their effect on the proteins embedded within
the IMM. In order to confirm this postulation, future work
should aim to perform electrophysiology on mitochondria and/or
mitoplasts (mitochondria that have been stripped of their
OMM, leaving the IMM exposed). Gaining electrophysiological
recordings of the ionic currents across both membranes
would inform us of the possible trafficking of the AGs into
mitochondria. Alternatively, the binding of gentamicin to
mitochondria has been shown to be persistent and not readily
reversible when tested in vitro (Kornguth et al., 1980), so
perhaps a certain amount must bind before the detrimental
effects are observed. Once conclusive, drug development projects
could work to design compounds capable of preventing the
observed effect of AGs on mitochondria, thereby minimizing
the unfortunate side effects associated with these clinically
invaluable antibiotics.
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